Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01379365 · ClinicalTrials.gov registry record · Phase 2
Cryo-Touch III Refinement Study Investigational Plan
A Phase 2 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
NCT01379365 is a Phase 2 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 88 participants.
The verdict
NCT01379365, a Phase 2 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch III device for the treatment of glabellar and/or forehead wrinkles.
Interventions
- DEVICE Cryo-Touch III
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01379365
The ClinicalTrials.gov registry entry for NCT01379365 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryo-Touch III is the first listed.
NCT01379365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01379365 about?
NCT01379365 is a clinical study titled "Cryo-Touch III Refinement Study Investigational Plan". This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch III device for the treatment of glabellar and/or forehead wrinkles.
What is the current status of trial NCT01379365?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2011-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01379365?
The interventions under investigation include: Cryo-Touch III (DEVICE).
Who is sponsoring clinical trial NCT01379365?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.